Re-framing the importance of Group B Streptococcus as a gut-resident pathobiont

Abstract excerpt

, GBS) is a Gram-positive bacterial species that causes disease in humans across the lifespan. While antibiotics are used to mitigate GBS infections, it is evident that antibiotics disrupt human microbiomes (which can predispose people to other diseases later in life), and antibiotic resistance in GBS is on the rise. Taken together, these unintended negative impacts of antibiotics highlight the need for precision...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neonatal and Maternal Infections
• Share to Pneumonia and Respiratory Infections
• Share to Streptococcal Infections and Treatments